"Ceftriaxone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to meninges, eyes and inner ears.
| Descriptor ID |
D002443
|
| MeSH Number(s) |
D02.065.589.099.249.190.190.155 D02.886.665.074.190.190.155 D03.633.100.300.249.190.190.155
|
| Concept/Terms |
Ceftriaxone Sodium- Ceftriaxone Sodium
- Sodium, Ceftriaxone
- Ceftriaxone, Disodium Salt, Hemiheptahydrate
- Ceftriaxone, Disodium Salt
Ro13-9904- Ro13-9904
- Ro13 9904
- Ro139904
- Ro-13-9904
- Ro 13-9904
- Ro 13 9904
- Ro 139904
Rocephin- Rocephin
- Rocefalin
- Rocephine
- Rocefin
|
Below are MeSH descriptors whose meaning is more general than "Ceftriaxone".
Below are MeSH descriptors whose meaning is more specific than "Ceftriaxone".
This graph shows the total number of publications written about "Ceftriaxone" by people in this website by year, and whether "Ceftriaxone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2023 | 1 | 0 | 1 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ceftriaxone" by people in Profiles.
-
Efficacy and safety of oral type II topoisomerase inhibitors versus ceftriaxone-based regimens for the treatment of gonorrhoea: A systematic review and meta-analysis of randomised controlled trials. J Infect Chemother. 2026 Sep; 32(9):103038.
-
Biliary Complications of Prolonged Ceftriaxone Use in Patients With Intracranial Infections. J Pediatric Infect Dis Soc. 2023 06 30; 12(6):379-380.
-
Time to First Culture Positivity for Gram-Negative Rods Resistant to Ceftriaxone in Critically Ill Adults. J Intensive Care Med. 2021 Jan; 36(1):51-57.
-
Documentation of Indications: Agreement Between Order Entry and Clinical Notes and Effect on Time to Antibiotic Administration. J Pharm Pract. 2022 Feb; 35(1):13-19.
-
Ceftriaxone-induced immune hemolytic anemia in a case with large vestibular aqueduct syndrome after cochlear implant. Chin Med J (Engl). 2019 Jan 05; 132(1):100-102.
-
A novel STK1-targeted small-molecule as an "antibiotic resistance breaker" against multidrug-resistant Staphylococcus aureus. Sci Rep. 2017 07 11; 7(1):5067.
-
Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis. J Clin Pharmacol. 2014 Oct; 54(10):1180-7.
-
Prediction of major antibiotic resistance in Escherichia coli and Klebsiella pneumoniae in Singapore, USA and China using a limited set of gene targets. Int J Antimicrob Agents. 2014 Jun; 43(6):563-5.
-
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. PLoS One. 2013; 8(4):e61177.
-
Primary meningococcal arthritis requiring surgical drainage. J Clin Rheumatol. 2013 Mar; 19(2):94-7.